Iria Pharma

60 Hazelwood Dr. Champaign, IL

Iria Pharma, LLC is dedicated to developing novel cancer-targeting technology and therapeutics. Iria’s leading technology, Active Tissue Targeting via Anchored Click Chemistry (ATTACK), is an innovative cancer-targeting technology that selectively labels cancer cells with proprietary unnatural sugars and targets the artificial label for improved drug delivery. The technology shows excellent improvement for tumor-targeted drug accumulation with significantly improved efficacy and lower side effects. Iria is actively seeking commercial partners and strategic collaborators for translational research and development.

Iria Pharma at Research Park